STAT+: Pharmalittle: J&J rivals rebuff bid to jointly study Covid-19 vaccine risks; will next-gen Covid shots be better or worse?
And so, another working week will soon draw to a close. Not a moment too…
Author: STAT
‘We did need to throw a lot of spaghetti against the Covid window’: a biotech analyst on pandemic drug development
The pandemic has shined a spotlight on the biopharmaceutical industry, proving its value through the…
Opinion: STAT+: Developers of microbiome-based drugs face challenges. There are ways to overcome them
Manipulating the human microbiome appears to be an effective approach for treating a range of…
Opinion: A ketogenic diet brought me back to life. Will believing in its effectiveness make me a pariah in medical school?
My awareness of the limits of medical knowledge began when I was diagnosed with osteoporosis…
Next-generation Covid-19 vaccines are supposed to be better. Some experts worry they could be worse
With Covid-19 vaccines, the world hopes to beat back the virus that causes the disease….
STAT+: A drug maker sues a medical journal, its editor, and several authors for libel
In an unusual move, Pacira Biosciences (PCRX) has filed a libel lawsuit against a medical…
Listen: J&J’s vaccine pause, how to talk about remote risks, & why we don’t have new drugs for Covid-19
How do you describe a one-in-a-million risk? What’s heparin-induced thrombocytopenia? And why’s it so hard…
STAT+: Thermo Fisher buys contract-research company PPD for $17.4 billion
Thermo Fisher Scientific announced Thursday that it will buy PPD, a contract-research company for the…
STAT+: Hints emerge about a key Senate committee’s plans for health care
WASHINGTON — A Senate hearing Thursday provided one of the clearest roadmaps to date for…
STAT+: WTO head urges movement on controversial Covid-19 vaccine proposal, but objections remain
Amid mounting pressure to widen global access to Covid-19 vaccines, the head of the World…
International team creates first chimeric human-monkey embryos
A team of scientists from the U.S., China, and Spain reported Thursday they have created…
STAT+: In a sharp rebuke, health officials toss Trump-era proposal to exempt medical AI tools from review
In a searing rebuke, the Biden administration is formally withdrawing a last-minute proposal by the…
STAT+: Pharmalittle: Pause for J&J Covid-19 shot to continue at least a week; Biden expands candidate list for FDA commish
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: WHO warns the world is still failing to develop desperately needed antibiotics
Despite mounting concern over antibiotic resistance, a new report finds that none of 43 antibiotics…
FDA wants more data on promising ALS drug, frustrating patients seeking faster access
People living with amyotrophic lateral sclerosis, or ALS, in the U.S. will have to wait…
Merck to continue tests of Covid pill, but stop trial in hospitalized patients
Merck said Thursday that it has seen “encouraging” results in a clinical trial of an…
Opinion: It’s time to get health care value assessment right
Trying to gauge the value of new drugs and devices is becoming increasingly important in…
Opinion: STAT+: Rethinking triage in an era of vaccine nationalism
Just about every schoolchild learns that Napoleon Bonaparte was a small man. But few know…
Watch: You got vaccinated. Now what?
Covid-19 vaccines are great tools for combating the pandemic, and are becoming widely available in…
Watch: You got vaccinated. Now what?
Covid-19 vaccines are great tools for combating the pandemic, and are becoming widely available in…
Glucose monitors revolutionized diabetes care. Now digital health startups want to bring them to the masses
For the 1.6 million people in America living with type 1 diabetes, a continuous glucose…
CDC advisory panel delays decision on Johnson & Johnson Covid-19 vaccine
The U.S. government’s recommended pause on use of the Johnson & Johnson Covid-19 vaccine is…
First-of-its-kind study pits psilocybin against a common antidepressant
Can psilocybin, the active ingredient in psychedelic mushrooms, match the depression-combatting capabilities of a commonly…
STAT+: FDA is urged to move faster to list medicines withdrawn over safety concerns
Arguing patient safety is at risk, an advocacy group is urging the Food and Drug…
STAT+: Tango Therapeutics to go public in $353 million SPAC deal
Cambridge biotech Tango Therapeutics is going public through a $353 million deal with a special…
STAT+: Pharmalittle: Pfizer to boost Covid-19 vaccine production for the U.S.; J&J faces new test with Covid-shot pause
Hello, everyone, and welcome to the middle of the week. You made it this far,…
Opinion: Listen: Two addiction specialists debunk the myth of ‘excited delirium’ used in police encounters
In the tenth episode of “The First Opinion Podcast,” I talk with two physicians who…
Opinion: Looking back at 15 years of sharing viral genomes to forge ahead
Anniversaries represent an opportunity for revisiting the past to make a leap forward. I’m using…
Opinion: Beware the ‘last mile, first smile’ syndrome when we near the end of the Covid-19 pandemic
Fatigue, distracted attention, and the sense that a crisis will soon be over contribute to…
A deathbed double standard: It’s hard to get released on medical parole — unless you’re about to become a Covid-19 statistic
During his 39 years in prison, the closest Joseph Messere ever came to walking free…
STAT+: Heralding a ‘societal transformation’ in health care, Mayo Clinic launches two companies to harness patient data
Mayo Clinic is forming a pair of companies to collect and analyze data from remote…
STAT+: A U.S. appeals court upholds the FTC view of controversial pay-to-delay settlements
In what is being called a win for consumers, a U.S. appeals court upheld a…
STAT+: PhRMA chief talks strategy — and he’s surprisingly optimistic about drug pricing reform
WASHINGTON — Steve Ubl, who leads the drug industry lobbying powerhouse PhRMA, has a bold…
STAT+: STAT+ Conversations: A conversation on the latest in neuroscience and CNS drug development
Editors note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: U.S. urges states to pause J&J Covid-19 shots; PhRMA’s new message says ‘Don’t take us for granted’
Rise and shine, another busy day is on the way. However, this is also shaping…
Researchers search for answers in puzzle of blood clots and Covid vaccines — and see some clues
A week after receiving the AstraZeneca Covid-19 vaccine, a 37-year-old woman in Norway went to…
U.S. urges pause on use of Johnson & Johnson Covid-19 vaccine after rare blood clotting cases
Federal authorities on Tuesday recommended that states stop using Johnson & Johnson’s Covid-19 vaccine while…
Opinion: Building the perfect wearable for clinical trials
The pace of innovation in wearable technology has never been faster. As often as once…
Opinion: No evidence that patents slow access to vaccines
At this point in the exhausting and deadly Covid-19 pandemic, people around the globe are…
STAT+: Europe tries to lower drug prices with small doses of transparency
For countries in Europe, negotiating a deal with a pharma company over drug prices is…
Huntington’s community grieves not just one therapeutic setback, but two
For the community of people affected by Huntington’s disease — a group that is no…
PhRMA’s new message to Washington: Don’t take us for granted
WASHINGTON — Pharmaceutical companies have a frank new message for Washington: Don’t take us for…
STAT+: Federal agency says pharma should pay higher Medicaid rebates if certain trials aren’t finished on time
In a bid to lower prescription drug costs, a federal agency is recommending pharmaceutical companies…
STAT+: Microsoft to buy Nuance Communications for $19.7 billion
Microsoft announced on Monday that it has agreed to acquire Burlington-based artificial intelligence and technology…
STAT+: Cavazzoni to take over influential spot atop FDA drug center
WASHINGTON — Patrizia Cavazzoni has been named the permanent leader of the FDA’s Center for…
STAT+: Pharmalittle: Regeneron antibody reduced Covid-19 infection risk; variant first seen in South Africa can somewhat ‘break through’ Pfizer shot
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Amazon established a foothold in diagnostics during Covid-19. Now it’s doubling down
Vin Gupta’s hiring in January 2020 could not have come at a better time for…
STAT+: Sage drug reduces muscle tremor but with significant side effects, study results show
Sage Therapeutics said Monday that its experimental pill was more effective than a placebo in…
Opinion: STAT+: Three steps toward creating a functioning U.S. biosimilars market
The development of safe, effective, and innovative biologic medicines is one of modern medicine’s far-reaching…
Opinion: Make it easier for employers to help get America vaccinated
Businesses across the country are ready, willing, and able to help America get vaccinated. They…